Search results
Results from the WOW.Com Content Network
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s, but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
Dengue fever is a mosquito-borne disease caused by dengue virus, prevalent in tropical and subtropical areas. It is frequently asymptomatic ; if symptoms appear they typically begin 3 to 14 days after infection.
Australia [1] Hong Kong [2] India [3] Malaysia [4] United Kingdom [5] United States [6] Acquired Immunodeficiency Syndrome (AIDS) Acquired immunodeficiency syndrome: Regional arbovirus infections: Barmah Forest, Murray Valley encephalitis virus infection, Ross River virus infection Dengue fever, Japanese encephalitis, other hemorrhagic fevers
So far in 2024, cases of dengue fever in countries in the Americas have reached record-breaking levels, with more than 9.7 million reported cases — twice the number for the entire year in 2023 ...
For perspective, there have been 2,559 cases of dengue fever reported in U.S. states and territories since the start of 2024, per the CDC. A large majority of those (1,724) were reported in Puerto ...
Dengue fever is caused by four viruses, so a person can be infected four times in their lifetime. Only about 1 in 4 people are symptomatic the first time they’re infected, according to the CDC.
Dengue fever: a Wikipedia clinical review Open Medicine. October 2, 2014. Vol. 8(4), pp.105-115. James M Heilman, Jacob F de Wolff, Graham M Beards, Brian J Basden: Author: James M Heilman, Jacob F de Wolff, Graham M Beards, Brian J Basden, with contributions from multiple Wikipedia contributors
When detected early and with access to medical care, the mortality rate of dengue is less than 1%—though that figure rises to 2-5% for severe dengue cases. If left untreated, however, the ...